{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Medford",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "86098",
      "recalling_firm": "Chembio Diagnostics, Inc",
      "address_1": "3661 Horseblock Rd",
      "address_2": "N/A",
      "postal_code": "11763-2215",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide",
      "recall_number": "Z-2807-2020",
      "product_description": "Chembio DPP COVID-19 IgM/IgG System- Rrapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Model Number: 65-9569-0",
      "product_quantity": "7,674 kits (153,480 devices)",
      "reason_for_recall": "FDA revocation of the Emergency Use Authorization due to performance issues",
      "recall_initiation_date": "20200618",
      "center_classification_date": "20200814",
      "termination_date": "20210811",
      "report_date": "20200826",
      "code_info": "Lot Numbers:  CV041020/A  CV041520  CV040220/A1  CV042420  CV042920  CV040320/A2  CV050120"
    }
  ]
}